Dis-Chem Pharmacies
Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments, Retail and Wholesale. It owns and operates a chain of retail stores that offers various products, including dispensary, personal care and beauty, healthcare and nutrition, baby care, and other produc… Read more
Dis-Chem Pharmacies (DCP) - Net Assets
Latest net assets as of August 2025: ZAC5.65 Billion ZAC
Based on the latest financial reports, Dis-Chem Pharmacies (DCP) has net assets worth ZAC5.65 Billion ZAC as of August 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ZAC19.37 Billion) and total liabilities (ZAC13.72 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ZAC5.65 Billion |
| % of Total Assets | 29.15% |
| Annual Growth Rate | 16.17% |
| 5-Year Change | 77.15% |
| 10-Year Change | 522.73% |
| Growth Volatility | 20.18 |
Dis-Chem Pharmacies - Net Assets Trend (2014–2025)
This chart illustrates how Dis-Chem Pharmacies's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Dis-Chem Pharmacies (2014–2025)
The table below shows the annual net assets of Dis-Chem Pharmacies from 2014 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-02-28 | ZAC5.23 Billion | +16.85% |
| 2024-02-29 | ZAC4.47 Billion | +13.79% |
| 2023-02-28 | ZAC3.93 Billion | +16.15% |
| 2022-02-28 | ZAC3.39 Billion | +14.70% |
| 2021-02-28 | ZAC2.95 Billion | +27.55% |
| 2020-02-29 | ZAC2.31 Billion | +9.89% |
| 2019-02-28 | ZAC2.11 Billion | +24.82% |
| 2018-02-28 | ZAC1.69 Billion | +49.25% |
| 2017-02-28 | ZAC1.13 Billion | +34.63% |
| 2016-02-29 | ZAC839.68 Million | -35.49% |
| 2015-02-28 | ZAC1.30 Billion | +29.49% |
| 2014-02-28 | ZAC1.01 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Dis-Chem Pharmacies's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 500.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (February 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ZAC3.72 Billion | 71.35% |
| Common Stock | ZAC6.16 Billion | 117.96% |
| Total Equity | ZAC5.22 Billion | 100.00% |
Dis-Chem Pharmacies Competitors by Market Cap
The table below lists competitors of Dis-Chem Pharmacies ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Vanachai Group Public Company Limited
BK:VNG
|
$16.58 Million |
|
Cohen & Company Inc
NYSE MKT:COHN
|
$16.58 Million |
|
FLANIGANS ENTER. DL-1
F:0DY
|
$16.58 Million |
|
Hyperion DeFi, Inc.
NASDAQ:HYPD
|
$16.59 Million |
|
SelfWealth Limited
AU:SWF
|
$16.56 Million |
|
Barington/Hilco Acquisition
NASDAQ:BHAC
|
$16.56 Million |
|
The Furukawa Battery Co. Ltd
F:FBB
|
$16.55 Million |
|
Hugoton Royalty Trust
OTCQB:HGTXU
|
$16.54 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Dis-Chem Pharmacies's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 4,472,124,000 to 5,218,221,000, a change of 746,097,000 (16.7%).
- Net income of 1,179,809,000 contributed positively to equity growth.
- Dividend payments of 471,989,000 reduced retained earnings.
- Share repurchases of 32,604,000 reduced equity.
- Other comprehensive income increased equity by 4,578,581,000.
- Other factors decreased equity by 4,507,700,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ZAC1.18 Billion | +22.61% |
| Dividends Paid | ZAC471.99 Million | -9.05% |
| Share Repurchases | ZAC32.60 Million | -0.62% |
| Other Comprehensive Income | ZAC4.58 Billion | +87.74% |
| Other Changes | ZAC-4.51 Billion | -86.38% |
| Total Change | ZAC- | 16.68% |
Book Value vs Market Value Analysis
This analysis compares Dis-Chem Pharmacies's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 559.08x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 3108.26x to 559.08x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-02-28 | ZAC1.09 | ZAC3400.00 | x |
| 2015-02-28 | ZAC1.42 | ZAC3400.00 | x |
| 2016-02-29 | ZAC0.84 | ZAC3400.00 | x |
| 2017-02-28 | ZAC1.36 | ZAC3400.00 | x |
| 2018-02-28 | ZAC1.90 | ZAC3400.00 | x |
| 2019-02-28 | ZAC2.37 | ZAC3400.00 | x |
| 2020-02-29 | ZAC2.62 | ZAC3400.00 | x |
| 2021-02-28 | ZAC3.38 | ZAC3400.00 | x |
| 2022-02-28 | ZAC3.86 | ZAC3400.00 | x |
| 2023-02-28 | ZAC4.53 | ZAC3400.00 | x |
| 2024-02-29 | ZAC5.21 | ZAC3400.00 | x |
| 2025-02-28 | ZAC6.08 | ZAC3400.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Dis-Chem Pharmacies utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 22.61%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.01%
- • Asset Turnover: 2.03x
- • Equity Multiplier: 3.69x
- Recent ROE (22.61%) is below the historical average (35.73%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 43.40% | 3.96% | 3.49x | 3.14x | ZAC314.44 Million |
| 2015 | 35.60% | 3.36% | 3.65x | 2.90x | ZAC311.83 Million |
| 2016 | 70.97% | 3.40% | 2.91x | 7.15x | ZAC440.52 Million |
| 2017 | 55.32% | 3.55% | 2.93x | 5.33x | ZAC501.66 Million |
| 2018 | 41.93% | 3.50% | 2.74x | 4.37x | ZAC521.07 Million |
| 2019 | 36.05% | 3.43% | 2.42x | 4.34x | ZAC530.93 Million |
| 2020 | 26.55% | 2.49% | 2.27x | 4.70x | ZAC372.89 Million |
| 2021 | 22.99% | 2.54% | 1.99x | 4.53x | ZAC377.82 Million |
| 2022 | 25.68% | 2.81% | 2.16x | 4.23x | ZAC521.06 Million |
| 2023 | 25.64% | 3.06% | 2.11x | 3.98x | ZAC610.18 Million |
| 2024 | 22.01% | 2.71% | 2.07x | 3.91x | ZAC537.27 Million |
| 2025 | 22.61% | 3.01% | 2.03x | 3.69x | ZAC657.99 Million |
Industry Comparison
This section compares Dis-Chem Pharmacies's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $1,221,757,000
- Average return on equity (ROE) among peers: 11.97%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Dis-Chem Pharmacies (DCP) | ZAC5.65 Billion | 43.40% | 2.43x | $16.57 Million |
| Clicks (CLS) | $1.22 Billion | 11.97% | 1.02x | $36.15 Million |